News
-
-
PRESS RELEASE
Aurubis AG appoints Chief Executive Officer and Chief Operations Officer, completing the restructuring of the Executive Board (correction)
Aurubis AG appoints Dr. Toralf Haag as CEO and Tim Kurth as COO, completing Executive Board restructuring. Haag brings extensive industry experience -
-
-
PRESS RELEASE
Aurubis AG appoints Chief Executive Officer and Chief Operations Officer, completing the restructuring of the Executive Board
Aurubis AG appoints new CEO and COO, completing Executive Board restructuring. Dr. Toralf Haag and Tim Kurth to take office on Sep 1, 2024, ensuring a smooth transition -
PRESS RELEASE
EQS-Adhoc: Aurubis AG: Supervisory Board appoints new CEO and COO
Aurubis AG's Supervisory Board appoints new CEO and COO. Dr. Toralf Haag as CEO and Tim Kurth as COO effective September 1, 2024. Inge Hofkens continues as COO for recycling area. Steffen Hoffmann to be CFO on October 1, 2024 -
-
PRESS RELEASE
More strategic metals for Europe: Aurubis commissions modernized tankhouse in Lünen
Aurubis commissions modernized tankhouse in Lünen, investing € 60 million to increase copper cathodes production capacity by 10% and process various strategic metals. Upgrade completed on schedule with state-of-the-art technology -
-
![Accesswire](/assets/images/accesswire-inline.png)
-
APWG 2024 Cybercrime Research Conference Extends Submission Deadline to July 7
-
Product Creation Studio Partners With PatchClamp Medtech Inc. to Develop Revolutionary Dural Repair System
-
XS Financial Enters Into Definitive Agreement to Be Taken Private
-
TRU Engages Investor Relations Specialists HE Capital Markets
-
DuJour Media Jason Binn Celebrates Successful 12th Anniversary Cover Party with Star-Studded After-Party and Record Turnout
![EQS Group](/assets/images/eqs-group.png)
-
Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
-
HORNBACH Group delivers strong Q1 2024/25 results increasing earnings per share y-o-y by 44% – full-year outlook confirmed unchanged
-
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
-
Meyer Burger makes significant progress in relocating its core business to the USA
-
BIRKENSTOCK ANNOUNCES LAUNCH OF SECONDARY OFFERING
![Les Echos](/assets/images/les-echos.png)
-
Gimv increases its stake in TINC – Gimv and Belfius conclude agreement in principle on the sale of the shares of Belfius Insurance in TINC
-
Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2024
-
2023/2024 Third Quarter Sales
-
Disclosure of trading in own shares from June 17th, 2024, to June 21th, 2024. Detailed information per transaction
-
Disclosure of trading in own shares from June 17th, 2024, to June 21th, 2024